Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.87)
# 1,763
Out of 5,063 analysts
26
Total ratings
47.37%
Success rate
10.09%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $14.47 | +58.95% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $32.06 | +71.55% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $24.21 | +28.05% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.96 | +152.02% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.38 | +334.78% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.70 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $16.43 | +52.16% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $2.48 | +9,577.42% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $31.53 | +153.73% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.54 | +251.68% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.95 | +713.56% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $1.94 | +102,992.78% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.06 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $14.47
Upside: +58.95%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $32.06
Upside: +71.55%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $24.21
Upside: +28.05%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.96
Upside: +152.02%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.38
Upside: +334.78%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.70
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $16.43
Upside: +52.16%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $2.48
Upside: +9,577.42%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $31.53
Upside: +153.73%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.54
Upside: +251.68%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.95
Upside: +713.56%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $1.94
Upside: +102,992.78%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.06
Upside: -